Drugs Policy in Developing Countries
Proud to be B-Corp
The feel-good place to buy books
Drugs Policy in Developing Countries by Najmi Kanji
This policy-relevant study grew out of an evaluation conducted by its authors - all scholars at the London School of Hygiene & Tropical Medicine and the Royal Tropical Institute, Amsterdam - of the World Health Organization's Action Programme on Essential Drugs. Their review, involving 13 country studies and WHO's five regional offices, looks at how the idea of a rational drug policy in developing countries came about, evaluates the achievements in specific countries, and discusses some of the issues that remain to be resolved - particularly issues around AIDs, contraception and cost recovery. It should prove useful to policy makers and academics, teachers and students, managers and professionals, as well as international agencies in the health field.
'Anyone who wants to understand the limitations and constraints of developing and executing a global policy to improve health in developing countries will find this book essential reading'
Calvin M. Kunin, M.D., Department of Internal Medicine, Ohio State University
'This book comes as a welcome reminder of the many efforts to develop policies for a more rational use of medecines. It provides a clear outline of some of the possible strategies to achieve change.'
Andrew Chetley, author of A Healthy Business: World Health and the Pharmaceutical Industry
'The WHO has succeeded in making "essential drugs" a respected concept. This book documents this crucial step in the improvement of the supply of medicines for people in the South.'
Sjaak van der Geest, University of Amsterdam
Calvin M. Kunin, M.D., Department of Internal Medicine, Ohio State University
'This book comes as a welcome reminder of the many efforts to develop policies for a more rational use of medecines. It provides a clear outline of some of the possible strategies to achieve change.'
Andrew Chetley, author of A Healthy Business: World Health and the Pharmaceutical Industry
'The WHO has succeeded in making "essential drugs" a respected concept. This book documents this crucial step in the improvement of the supply of medicines for people in the South.'
Sjaak van der Geest, University of Amsterdam
Najmi Kanji is a research fellow in the Health Policy Unit at the London School of Hygiene & Tropical Medicine.
Anita Hardon is a medical biologist in the Medical Anthropology Unit of the University of Amsterdam.
Jan Willem Harnmeijer works in the Primary Health Care Unit at the Royal Tropical Institute in Amsterdam.
Masuma Mamdani is an epidemiologist and research fellow at the London School of Hygiene & Tropical Medicine.
Gill Walt is a senior lecturer and head of the Health Policy Unit at the London School of Hygiene & Tropical Medicine
Anita Hardon is a medical biologist in the Medical Anthropology Unit of the University of Amsterdam.
Jan Willem Harnmeijer works in the Primary Health Care Unit at the Royal Tropical Institute in Amsterdam.
Masuma Mamdani is an epidemiologist and research fellow at the London School of Hygiene & Tropical Medicine.
Gill Walt is a senior lecturer and head of the Health Policy Unit at the London School of Hygiene & Tropical Medicine
| SKU | Nicht verfügbar |
| ISBN 13 | 9781856490603 |
| ISBN 10 | 1856490602 |
| Titel | Drugs Policy in Developing Countries |
| Autor | Najmi Kanji |
| Buchzustand | Nicht verfügbar |
| Bindungsart | Paperback |
| Verlag | Zed Books |
| Erscheinungsjahr | 1992-09-01 |
| Seitenanzahl | 152 |
| Hinweis auf dem Einband | Die Abbildung des Buches dient nur Illustrationszwecken, die tatsächliche Bindung, das Cover und die Auflage können sich davon unterscheiden. |
| Hinweis | Nicht verfügbar |